Sense Neuro Diagnostics OK'd For New Trial, Its Last As It Nears Commercialization

"A Cincinnati medtech startup is celebrating a “watershed moment” as it edges closer to commercialization following a key approval from the U.S. Food and Drug Administration.

"Sense Neuro Diagnostics said the FDA approved its application to move forward with a new clinical trial to develop a device for detecting bleeding in the brain – a study that will stand as its final hurdle before market launch."

-Liz Engel, Cincinnati Business Courier

Click here to read more about Threshold client Sense Neuro Diagnostics.